Fermenta Biotech

Fermenta Biotech Short-term Debt

The Short-Term Debt of Fermenta Biotech (506414.BO) as of Oct 19, 2026 is 798.62 M INR. In the previous year, Short-Term Debt was 691.75 M INR — a change of 15.45% (higher).

Short-term Debt

798.62 MINR

YoY

15.45%

Last updated:

Short-Term Debt of Fermenta Biotech is 2025 798.62 M INR. Short-Term Debt of Fermenta Biotech was 2024 691.75 M INR. It decreases by 15.45% higher compared to the previous year.

The Fermenta Biotech Short-term Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Short-term Debt
Date
Short-term Debt
Jan 1, 2018
298.55 M INR
Jan 1, 2019
602.13 M INR
Jan 1, 2020
1.04 B INR
Jan 1, 2021
963.00 M INR
Jan 1, 2022
974.75 M INR
Jan 1, 2023
1.01 B INR
Jan 1, 2024
691.75 M INR
Jan 1, 2025
798.62 M INR
The Fermenta Biotech Short-term Debt history
YEARShort-term DebtYoY
798.62 MINR+15.45%
691.75 MINR-31.82%
1.01 BINR+4.08%
974.75 MINR+1.22%
963.00 MINR-7.70%
1.04 BINR+73.27%
602.13 MINR+101.68%
298.55 MINR-66.28%
885.50 MINR-0.28%
887.97 MINR+25.35%
708.38 MINR+8.79%
651.12 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Fermenta Biotech Stock analysis

What does Fermenta Biotech do? Fermenta Biotech Ltd is a pharmaceutical company headquartered in Thane, India, listed on the stock exchange on 4 January 1990. With a workforce of 550 employees, the firm operates primarily in the manufacturing and supply of Vitamin D3 and other bulk drugs. Its Chemicals and Bulk Drug segment produces enzymes and specialized technologies for the biopharmaceutical life cycle, serving industries such as pharmaceuticals, animal feed, and food fortification. Additionally, the company offers nutritional ingredients like fish oil-derived cholesterol and natural astaxanthin. The Property segment complements these operations by managing the renting and sale of real estate assets. Fermenta Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Fermenta Biotech stock

Short-Term Debt of Fermenta Biotech is 798.62 M INR in 2025.

Short-Term Debt of Fermenta Biotech changed from 691.75 M INR to 798.62 M INR, representing a 15.45% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Short-Term Debt Fermenta Biotech since 2006 – with annual values, charts, and detailed analysis.

Short-term debt represents borrowings due within one year. High short-term debt relative to cash can signal liquidity risk.

Short-Term Debt's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Short-Term Debt's Fermenta Biotech historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Fermenta Biotech

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Fermenta Biotech